Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.8K
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solution-solid-solid mechanism: superionic conductors catalyze nanowire growth.

Nano letters·2013
Same author

Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM-induced autophagy or BAX.

Liver international : official journal of the International Association for the Study of the Liver·2013
Same author

Low-voltage switching of crease patterns on hydrogel surfaces.

Advanced materials (Deerfield Beach, Fla.)·2013
Same author

Long non-coding RNAs and prostate cancer.

Journal of nanoscience and nanotechnology·2013
Same author

Self-assembled graphene quantum dots induced by cytochrome c: a novel biosensor for trypsin with remarkable fluorescence enhancement.

Nanoscale·2013
Same author

Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.

Onkologie·2013
Same journal

Nanotechnology-Empowered Photodynamic Therapy for Improved Oral Cancer Treatment.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Design, Synthesis, Spectroscopic Analysis, and In Silico Molecular Docking Study of Novel Azo Compounds as Potential Antioxidant and Anti-Triple-Negative Breast Cancer Agents.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Plant-Derived Polyphenols in the Fight against Colorectal Cancer.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Emerging Frontiers in Nanomedicine for Colorectal Cancer: A Review of Therapeutic Advances, Clinical Evidence, and Patented Technologies.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Microfluidic Synthesis of miR-10a Antisense Oligonucleotides-Loaded LNP Combined with Cisplatin for Colorectal Cancer Therapy.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Synergistic Anticancer Effect of Luteolin and Etoposide via the PI3K/AKT Signaling Pathway.

Anti-cancer agents in medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.9K

Anticancer Drug Combinations, How Far We can Go Through?

Da-Yong Lu1, En-Hong Chen, Hong-Ying Wu

  • 1School of Life Sciences, Shanghai University, Shanghai200444, PR China.

Anti-Cancer Agents in Medicinal Chemistry
|April 5, 2016
PubMed
Summary
This summary is machine-generated.

Combining anticancer drugs may improve cancer treatment efficacy compared to single agents, but establishing optimal drug combinations remains challenging. This review explores current practices and future directions for combination cancer therapy.

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Related Experiment Videos

Last Updated: Mar 23, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Research

Background:

  • Single-agent anticancer therapies often face limitations due to cancer pathogenesis and acquired drug resistance in advanced stages.
  • Combination cancer therapy, using multiple drugs, is a widely accepted strategy to potentially enhance treatment outcomes and overcome resistance.
  • Despite clinical consensus, a definitive scientific framework, or dogma, for selecting effective anticancer drug combinations is lacking.

Purpose of the Study:

  • To review current practices and challenges in anticancer drug combination therapy.
  • To explore potential future strategies and identify drawbacks in the development of drug combinations.
  • To speculate on methodologies for establishing a robust drug combination dogma in cancer treatment.

Main Methods:

  • Literature review of existing clinical practices in combination cancer therapy.
  • Analysis of the complexities and challenges in discovering effective drug combinations.
  • Speculative discussion on future research routes and potential drawbacks.

Main Results:

  • Current clinical practice favors combination therapy, but lacks established principles for optimal selection.
  • The discovery of effective drug combinations is complex and requires further investigation.
  • Future research needs to address the complexities and potential pitfalls of combinative therapies.

Conclusions:

  • Anticancer drug combinations hold promise but require a more established scientific basis.
  • Further research is needed to overcome the complexities in developing effective drug combination strategies.
  • Understanding the landscape, including drawbacks, is crucial for advancing combination cancer therapy.